DECIDE Trial
Outcomes-based clinical evidence
Key Facts
About HeartFlow
HeartFlow's mission is to transform coronary artery disease from a leading cause of death into a proactively managed chronic condition. The company has achieved remarkable commercial success, with its technology deployed in over 1,800 institutions, used on 600,000+ patients, and secured near-universal U.S. insurance reimbursement. Its strategy centers on expanding its AI-powered platform from a diagnostic tool into a comprehensive, longitudinal management system for CAD, leveraging a vast and growing clinical evidence base.
View full company profile